Opus Point Partners Management’s iShares Biotechnology ETF IBB Stock Holding History

Opus Point Partners Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$12.4M	Hold	125,000	–	–	22.48%	1
2019 Q2	$13.6M	Hold	125,000	–	–	20.18%	1
2019 Q1	$14M	Hold	125,000	–	–	18.94%	1
2018 Q4	$12.1M	Buy	+125,000	New	+$13.3M	26.53%	1
2018 Q3	–	Sell	-18,750	Closed	-$2.06M	–	49
2018 Q2	$2.06M	Hold	18,750	–	–	4.47%	4
2018 Q1	$2M	Sell	18,750 -18,750	-50%	-$2.08M	3.92%	6
2017 Q4	$4M	Hold	37,500	–	–	3.46%	12
2017 Q3	$4.17M	Hold	37,500	–	–	3.74%	7
2017 Q2	$3.88M	Sell	37,500 -37,500	-50%	-$3.69M	3.55%	9
2017 Q1	$7.33M	Hold	75,000	–	–	5.44%	2
2016 Q4	$6.63M	Hold	75,000	–	–	5.29%	3
2016 Q3	$7.24M	Buy	75,000 +21,957	+41%	+$2.09M	4.06%	4
2016 Q2	$4.55M	Buy	+53,043	New	+$4.76M	4.39%	4
2016 Q1	–	Sell	-94,800	Closed	-$10.7M	–	55
2015 Q4	$10.7M	Buy	94,800 +34,800	+58%	+$3.78M	7.06%	1
2015 Q3	$6.07M	Buy	+60,000	New	+$7.2M	3.35%	2

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Opus Point Partners Management's IBB Position: Q3 2019 in Review

Opus Point Partners Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2019 at 125,000 shares worth $12.4M. The position accounts for 22.48% of the portfolio, ranked #1.

Opus Point Partners Management first reported a position in IBB in Q3 2015 and has held it in 15 quarters since. The position peaked at $14M in Q1 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Opus Point Partners Management held 125,000 shares of iShares Biotechnology ETF worth $12.4M as of Q3 2019.
Opus Point Partners Management left its iShares Biotechnology ETF share count unchanged in Q3 2019.
iShares Biotechnology ETF made up 22.48% of Opus Point Partners Management's portfolio in Q3 2019, its #1 holding.
Opus Point Partners Management first reported a position in iShares Biotechnology ETF in Q3 2015 and has held it in 15 quarters since.
Opus Point Partners Management's iShares Biotechnology ETF position peaked at $14M in Q1 2019.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.